KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Astrana Health (ASTH) over the last 16 years, with Q3 2025 value amounting to $17.7 million.

  • Astrana Health's Interest Expenses rose 10006.78% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 3292.94%. This contributed to the annual value of $33.1 million for FY2024, which is 10554.59% up from last year.
  • Per Astrana Health's latest filing, its Interest Expenses stood at $17.7 million for Q3 2025, which was up 10006.78% from $7.4 million recorded in Q2 2025.
  • Astrana Health's Interest Expenses' 5-year high stood at $17.7 million during Q3 2025, with a 5-year trough of $967000.0 in Q3 2021.
  • For the 5-year period, Astrana Health's Interest Expenses averaged around $5.0 million, with its median value being $3.6 million (2023).
  • As far as peak fluctuations go, Astrana Health's Interest Expenses tumbled by 6078.67% in 2021, and later surged by 20465.98% in 2023.
  • Quarter analysis of 5 years shows Astrana Health's Interest Expenses stood at $1.1 million in 2021, then surged by 144.72% to $2.6 million in 2022, then skyrocketed by 110.81% to $5.4 million in 2023, then surged by 48.82% to $8.1 million in 2024, then soared by 119.58% to $17.7 million in 2025.
  • Its Interest Expenses stands at $17.7 million for Q3 2025, versus $7.4 million for Q2 2025 and $7.3 million for Q1 2025.